v3.26.1
Leases (Tables) - Veraxa Biotech A G [Member]
 12 Months Ended
Dec. 31, 2025
Entity Information [Line Items]  
Schedule of weighted-average discount rate
       
    December 31,
2025		   December 31,
2024
Weighted-average remaining lease term   4.0 years   5.0 years
Weighted-average discount rate   3.0   3.0
Schedule of summarizes the maturities
       
2026   ₣ 291,276  
2027     296,938  
2028     305,846  
2029     315,022  
Total expected lease payments     1,209,082  
Less: imputed interest     (68,434 )
Total lease liability     1,140,648  
Less: current lease liability     (257,095 )
Non-current lease liability   ₣ 883,553